Related Experiment Video
Updated: Sep 27, 2025
11:18
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
16.2K
Translating "Big Data" in Oncology for Clinical Benefit: Progress or Paralysis
Anna D Barker1,2, Jerry S H Lee1,3
1Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, California.
Cancer Research
|April 13, 2022
Summary
Cancer research is generating vast amounts of data, leading to breakthroughs but also new challenges. Addressing these requires rebuilding our information systems for better patient outcomes.
Area of Science:
- Oncology
- Bioinformatics
- Genomics
Background:
- The cancer research-care continuum is experiencing a big data revolution.
- Genomics, multiomics, molecular-driven trials, and real-world data are key drivers.
- This revolution offers benefits but also presents significant challenges.
Purpose of the Study:
- To explore progress and key challenges in leveraging big data in cancer research.
- To identify areas for improvement in the information and evidence-based learning system.
Main Methods:
- Review of current advancements in cancer big data.
- Analysis of challenges encountered in data integration and utilization.
- Discussion of potential solutions for a learning health system.
Main Results:
- Big data has yielded benefits for some cancer patients.
- New problems and complexities have arisen from data proliferation.
- Existing information systems are insufficient to fully harness big data's potential.
Conclusions:
- The challenges posed by big data in cancer are significant but not insurmountable.
- Rethinking and rebuilding the information and evidence-based learning system is crucial.
- A transformed system is needed to move beyond current limitations and improve cancer care.
More Related Videos
Related Concept Videos
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:21Cancer Survival Analysis
472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:07Improving Translational Accuracy
11.9K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
11.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K